CA2079077A1 - Tissue glue prepared by using cryoprecipitate - Google Patents

Tissue glue prepared by using cryoprecipitate

Info

Publication number
CA2079077A1
CA2079077A1 CA2079077A CA2079077A CA2079077A1 CA 2079077 A1 CA2079077 A1 CA 2079077A1 CA 2079077 A CA2079077 A CA 2079077A CA 2079077 A CA2079077 A CA 2079077A CA 2079077 A1 CA2079077 A1 CA 2079077A1
Authority
CA
Canada
Prior art keywords
component
cryoprecipitate
tissue glue
glue prepared
fibrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2079077A
Other languages
French (fr)
Other versions
CA2079077C (en
Inventor
Uri Martinowitz
Frederic Bal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omrix Biopharmaceuticals SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8165612&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2079077(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2079077A1 publication Critical patent/CA2079077A1/en
Application granted granted Critical
Publication of CA2079077C publication Critical patent/CA2079077C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0005Ingredients of undetermined constitution or reaction products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088Liquid substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Packages (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Pyrane Compounds (AREA)

Abstract

A tissue glue is described comprising a component A which comprises a cryoprecipitate of whole blood and high an amount of a protease inhibitor corresponding to 3,000 to 5,000 KIU/ml units of aprotinin, and a component B comprising a proteolytic enzyme being capable of cleaving specifically fibrinogen present in component A and causing the formation of a fibrine polymer.
In another embodiment an improved tissue glue is described comprising a component A which comprises a cryoprecipitate of whole blood, and a component B comprising a proteolytic enzyme obtainable from snake venom which enzyme is capable of cleaving specifically fibrinogen present in component A and causing the formation of a fibrine polymer.
CA002079077A 1991-09-27 1992-09-24 Tissue glue prepared by using cryoprecipitate Expired - Fee Related CA2079077C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EPPCT/EP91/01850 1991-09-27
PCT/EP1991/001850 WO1993005822A1 (en) 1991-09-27 1991-09-27 Tissue glue prepared by using cryoprecipitate

Publications (2)

Publication Number Publication Date
CA2079077A1 true CA2079077A1 (en) 1993-03-28
CA2079077C CA2079077C (en) 1999-11-30

Family

ID=8165612

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002079077A Expired - Fee Related CA2079077C (en) 1991-09-27 1992-09-24 Tissue glue prepared by using cryoprecipitate

Country Status (15)

Country Link
JP (1) JP2668762B2 (en)
AT (1) ATE200631T1 (en)
AU (1) AU648198B2 (en)
BR (1) BR9203763A (en)
CA (1) CA2079077C (en)
CZ (1) CZ280540B6 (en)
DE (1) DE69231791T2 (en)
ES (1) ES2155437T3 (en)
FI (1) FI924306L (en)
HU (2) HUT67051A (en)
IL (1) IL103118A (en)
NO (1) NO316155B1 (en)
SK (1) SK294292A3 (en)
WO (1) WO1993005822A1 (en)
ZA (1) ZA927360B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE180492T1 (en) * 1991-09-05 1999-06-15 Baxter Int TOPICAL FIBRINOGEN COMPLEX
ITMI20021917A1 (en) * 2002-09-10 2004-03-11 New Dawn Consultores E Servicos L Da ACTIVATOR FOR THE FORMATION OF PLASTIC GEL, PLASMA GEL POOR OF PLATES OR PLASMA GEL RICH IN PLATES.
EP2011524A1 (en) 2007-07-02 2009-01-07 Omrix Biopharmaceuticals Ltd. Fibrin glue with a visualization agent
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
EP2331158B1 (en) 2008-09-22 2013-09-11 Omrix Biopharmaceuticals Ltd. Implantable device comprising a substrate pre-coated with stabilized fibrin
CA2787883C (en) 2010-01-28 2019-02-19 Erez Ilan Method for improved fibrin sealing
IL213864A0 (en) 2011-06-30 2011-08-31 Omrix Biopharmaceuticals Ltd Method for removing a lytic enzyme from a heterogeneous mixture
US10130346B2 (en) 2012-07-24 2018-11-20 Omrix Biopharmaceuticals Ltd. Device and method for the application of a curable fluid composition to a bodily organ
JP6246833B2 (en) 2012-12-30 2017-12-13 オムリックス・バイオファーマシューティカルズ・リミテッドOmrix Biopharmaceuticals Ltd. Apparatus and method for applying a curable fluid composition to a part of a body organ
USD754325S1 (en) 2013-06-06 2016-04-19 Omrix Biopharmaceuticals Ltd. Device of a curable fluid composition to a bodily organ
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One component fibrin glue comprising a polymerization inhibitor
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One component fibrin glue comprising zymogens
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen formulation
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for preparing and administering one-component fibrin sealant
IL234246A0 (en) 2014-08-21 2014-11-30 Omrix Biopharmaceuticals Ltd Stabilized thrombin
US10905716B2 (en) 2015-02-16 2021-02-02 Nayacure Therapeutics Ltd. Modified blood clots
IL247821A0 (en) 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Sealant formulations and uses thereof
IL249725A0 (en) 2016-12-22 2017-03-30 Omrix Biopharmaceuticals Ltd Hemostatic composition comprising an anion exchanger and a calcium salt
IL263679A (en) * 2018-12-12 2019-03-31 Omrix Biopharmaceuticals Ltd Kits, methods, and ingredients for preventing tissue adhesion

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359652B (en) * 1979-02-15 1980-11-25 Immuno Ag METHOD FOR PRODUCING A TISSUE ADHESIVE
ATE20824T1 (en) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg ENRICHED PLASMA DERIVES TO SUPPORT WOUND CLOSURE AND HEALING.
US4627879A (en) * 1984-09-07 1986-12-09 The Trustees Of Columbia University In The City Of New York Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma
DE3622642A1 (en) * 1986-07-05 1988-01-14 Behringwerke Ag ONE-COMPONENT TISSUE ADHESIVE AND METHOD FOR THE PRODUCTION THEREOF
DE68918155T2 (en) * 1988-05-02 1995-03-02 Matrix Pharma Surgical adhesive material.
FR2650508A1 (en) * 1989-08-01 1991-02-08 Fondation Nale Transfusion San PASTEURIZED ADHESIVE FOR JOINING HUMAN OR ANIMAL TISSUES

Also Published As

Publication number Publication date
NO923737D0 (en) 1992-09-25
WO1993005822A1 (en) 1993-04-01
NO923737L (en) 1993-03-29
IL103118A0 (en) 1993-02-21
CA2079077C (en) 1999-11-30
ATE200631T1 (en) 2001-05-15
DE69231791T2 (en) 2001-11-22
FI924306A7 (en) 1993-03-28
NO316155B1 (en) 2003-12-22
JPH05194263A (en) 1993-08-03
BR9203763A (en) 1993-04-20
AU2528892A (en) 1993-04-01
CZ294292A3 (en) 1994-02-16
AU648198B2 (en) 1994-04-14
FI924306L (en) 1993-03-28
ZA927360B (en) 1993-05-03
CZ280540B6 (en) 1996-02-14
HU211631A9 (en) 1995-12-28
HU9203070D0 (en) 1992-12-28
SK294292A3 (en) 1994-06-08
JP2668762B2 (en) 1997-10-27
DE69231791D1 (en) 2001-05-23
HUT67051A (en) 1995-01-30
ES2155437T3 (en) 2001-05-16
FI924306A0 (en) 1992-09-25
IL103118A (en) 1996-11-14

Similar Documents

Publication Publication Date Title
CA2079077A1 (en) Tissue glue prepared by using cryoprecipitate
CA2159469A1 (en) Two component fibrin glue
EP0998949A3 (en) Flexible wound dressing based on fibrin and process for preparation of same
CA2131316A1 (en) A thrombin blood fraction for use in a medical procedure
WO1990013306A3 (en) Small polypeptides
WO1999015209A3 (en) Fibrin sponge
CA2088343A1 (en) Stable fibrinogen solution
CA2295247A1 (en) Compositions containing thrombin and microfibrillar collagen
ATE250669T1 (en) PROTEOLYTIC ENZYMES AND THEIR USE IN DETERGENTS
FR2714288B1 (en) Elastomeric ear for disposable absorbent article and incorporating article.
AU587807B2 (en) Debriding tape
CA2069085A1 (en) Activatable fibrinolytic and anti-thrombotic proteins
EP0602173A4 (en) Topical fibrinogen complex.
CA2071651A1 (en) A parenterally administrable drug having thrombolytic activity and containing protein c
WO2001004146A3 (en) Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof
WO1997041206A3 (en) Von willebrand factor multimerase
CA2302224A1 (en) Fibrinogen-based tissue adhesive
AU6599194A (en) Angiotension (AII) antagonists as inhibitors of the growth of adipose tissue
AU670571B2 (en) A method of proteolytically cleaving proteins and the use of said method
AU4344789A (en) Proteolytic alkaline enzyme, production and use thereof
EP0942996B8 (en) Thrombolytic agents with antithrombotic activity
AU4996400A (en) A peptide inhibitor of fibrinogen blood clotting
ATE151295T1 (en) TWO-COMPONENT FIBRIN ADHESIVE TO IMPROVE IN-VITRO FERTILIZATION
AU2353688A (en) Modified tissue plasminogen activator
IE873398L (en) New plasminogen activators.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed